Phage M13 for the treatment of Alzheimer and Parkinson disease
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The new frontier of genome engineering with CRISPR-Cas9Science, 2014
- Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4Journal of Biological Chemistry, 2014
- Filamentous Phages Reduce α-Synuclein Oligomerization in the Membrane Fraction of SH-SY5Y CellsNeurodegenerative Diseases, 2010
- Modulation effect of filamentous phage on α-synuclein aggregationBiochemical and Biophysical Research Communications, 2009
- A Conformational Unfolding Reaction Activates Phage fd for the Infection of Escherichia coliJournal of Molecular Biology, 2007
- The economic impact of Parkinson's diseaseParkinsonism & Related Disorders, 2007
- Prolyl isomerization as a molecular timer in phage infectionNature Structural & Molecular Biology, 2005
- Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathologyProceedings of the National Academy of Sciences, 2003
- Immunization against Alzheimer's β-amyloid plaques via EFRH phage administrationProceedings of the National Academy of Sciences, 2000
- Infectious Nucleic Acids of Escherichia coli BacteriophagesEuropean Journal of Biochemistry, 1967